HUGE Stock, FSD Pharma Inc. Information

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative and inflammatory disorders. The three licensed drug candidates are LUCID-MS, a new chemical entity targeting multiple sclerosis, LUCID-PSYCH, a psychoactive molecule targeting major depressive disorder, and FSD-PEA, an ultra-micronized palmitoyl ethylamine with a favorable safety profile targeting inflammation.